121 related articles for article (PubMed ID: 37864896)
21. Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.
Durai L; Ravindran S; Arvind K; Karunagaran D; Vijayalakshmi R
Mol Biol Rep; 2021 Nov; 48(11):7443-7456. PubMed ID: 34716862
[TBL] [Abstract][Full Text] [Related]
22. Metformin is synthetically lethal with glucose withdrawal in cancer cells.
Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A
Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961
[TBL] [Abstract][Full Text] [Related]
23. Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells
Tang JC; An R; Jiang YQ; Yang J
Cancer Res Treat; 2017 Jul; 49(3):778-789. PubMed ID: 27857021
[TBL] [Abstract][Full Text] [Related]
24. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
[TBL] [Abstract][Full Text] [Related]
25. Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications.
García-Sáenz M; Lobaton-Ginsberg M; Ferreira-Hermosillo A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454163
[TBL] [Abstract][Full Text] [Related]
26. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
Li R; Li P; Wang J; Liu J
Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
[TBL] [Abstract][Full Text] [Related]
27. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
[TBL] [Abstract][Full Text] [Related]
28. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
29. Meta-Analysis of Microarray Expression Studies on Metformin in Cancer Cell Lines.
Schulten HJ; Bakhashab S
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261735
[TBL] [Abstract][Full Text] [Related]
30. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.
Banerjee A; Birts CN; Darley M; Parker R; Mirnezami AH; West J; Cutress RI; Beers SA; Rose-Zerilli MJJ; Blaydes JP
Carcinogenesis; 2019 Jul; 40(7):871-882. PubMed ID: 30668646
[TBL] [Abstract][Full Text] [Related]
31. HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA.
Wang JM; Jiang JY; Zhang DL; Du X; Wu T; Du ZX
J Cell Mol Med; 2021 May; 25(10):4814-4825. PubMed ID: 33792181
[TBL] [Abstract][Full Text] [Related]
32. Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion.
Yu Y; Feng C; Kuang J; Guo L; Guan H
Endocrine; 2022 Apr; 76(1):116-131. PubMed ID: 35050486
[TBL] [Abstract][Full Text] [Related]
33. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.
Park S; Willingham MC; Qi J; Cheng SY
Endocr Relat Cancer; 2018 Oct; 25(10):865-877. PubMed ID: 29914872
[TBL] [Abstract][Full Text] [Related]
34. Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.
Oliveras-Ferraros C; Vazquez-Martin A; Cuyàs E; Corominas-Faja B; Rodríguez-Gallego E; Fernández-Arroyo S; Martin-Castillo B; Joven J; Menendez JA
Cell Cycle; 2014; 13(7):1132-44. PubMed ID: 24553122
[TBL] [Abstract][Full Text] [Related]
35. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
37. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
[TBL] [Abstract][Full Text] [Related]
38. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
Chen G; Nicula D; Renko K; Derwahl M
Oncol Rep; 2015 Apr; 33(4):1994-2000. PubMed ID: 25683253
[TBL] [Abstract][Full Text] [Related]
39. DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis.
Zhu X; Xue C; Kang X; Jia X; Wang L; Younis MH; Liu D; Huo N; Han Y; Chen Z; Fu J; Zhou C; Yao X; Du Y; Cai W; Kang L; Lyu Z
Int J Biol Sci; 2022; 18(11):4372-4387. PubMed ID: 35864964
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of Koningic acid in thyroid cancer by inhibiting cellular glycolysis.
Jing C; Li Y; Gao Z; Wang R
Endocrine; 2022 Jan; 75(1):169-177. PubMed ID: 34264510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
